Consensus $2.49. The company said, “Baxter (BAX) now expects sales growth from continuing operations of 7% to 8% on a reported basis. On an operational basis, Baxter expects sales growth of 4% to 5%. The company now expects adjusted earnings from continuing operations, before special items, of $2.47 to $2.55 per diluted share, compared to prior guidance of $2.45 to $2.55 per diluted share.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX:
- Baxter call volume above normal and directionally bullish
- Is BAX a Buy, Before Earnings?
- Baxter participates in a conference call with JPMorgan
- Baxter International: Navigating Leadership Transition and Market Growth Amidst Tariff Challenges
- Baxter International Appoints New Leadership Amid Strategic Changes